SEARCH

SEARCH BY CITATION

References

  • 1
    Crosby WH. Paroxysmal nocturnal hemoglobinuria: a classic description by Paul Strübing in 1882, and a bibliography of the disease. Blood 1951; 6: 270284.
  • 2
    Savage WJ,Brodskey RA. New insights into paroxysmal nocturnal hemoglobinuria. Hematology 2007; 20: 1 (Epub ahead of print).
  • 3
    Parker C,Omine M,Richards S. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005; 12: 106112.
  • 4
    Hillmen P,Young NS,Schubert J. The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria. N Eng J Med 2006; 355: 12331243.
  • 5
    Hillmen P,Hall C,Marsh JC. Effect of Eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Eng J Med. 2004; 350: 552559.
  • 6
    Hillmen P,Muus P,Dührsen U. Effect of complement inhibitor Eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood 2007; 110: 41234128.
  • 7
    Hall C,Richards S,Hillmen P. Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood 2003; 11: 102110.
  • 8
    Audebert HJ,Planck J,Eisenburg M. Cerebral Ischemic Infarction in Paroxysmal Nocturnal Hemoglobinuria. Report of 2 Cases and Updated Review of 7 Previously Published Patients. J Neurol 2005; 252: 13791386.
  • 9
    Rother RP,Bell L,Hillmen P,Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293: 16531662.
  • 10
    De Stefano V,Fiorini A,Rossi E. Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Throm Haemost 2007; 5: 708714.